Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Oxford Biomedica Plc (OXB.LN)

Oxford Biomedica Plc (OXB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oxford Biomedica Plc Windrush Court Transport Way Oxford OX4 6LT GBR

https://www.oxb.com P: 186-578-3000

Description:

Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focuses on the field of immunotherapy by managing a platform of technologies for designing gene-based medicines. The company's operating segments include the Platform segment consists of the revenue-generating bioprocessing and process development activities undertaken for third parties. Its Product segment consists of the clinical and preclinical development of in vivo and ex vivo gene and cell therapy products. The company derives the maximum revenue from the Platform segment. Its Platform includes LentiVector, LentiStable, TRiPSystem, SecNuc, Analytics, and others. Geographically, it generates the majority of its revenue from Europe.

Key Statistics

Overview:

Market Capitalization, $K 287,001
Shares Outstanding, K 100,000
Annual Sales, $ 139,989 K
Annual Net Income, $ -39,157 K
% of Insider Shareholders 43.30%
% of Institutional Shareholders 31.48%

Growth:

1-Year Return -29.38%
3-Year Return -71.97%
5-Year Return -58.16%
5-Year Revenue Growth 30.08%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.64
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 05/30/18

OXB.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -31.27%
Return-on-Assets % -14.20%
Profit Margin % -27.97%
Debt/Equity 0.54
Price/Sales 3.09
Price/Book 3.88
Book Value/Share 0.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar